Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 298 of 6351
-
New drug cocktail targets rare liver cancer in 29-Patient trial
Disease control Not yet recruitingThis is a single arm phase 2 study of Single Tremelimumab with Regular Interval Durvalumab (STRIDE) plus Gemcitabine and Cisplatin (GEMCIS) in locally advanced unresectable/metastatic combined hepatocellular-cholangiocarcinoma (cHCC-CCA). Cycles 1 through 8 will be in 3 week inte…
Phase 2 • Sponsor: Mehmet Akce • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a vaccine stop cancer before it starts in lynch syndrome?
Prevention Not yet recruitingThe aim of this study is to assess safety, immunogenicity and feasibility of vaccination with neopeptide-loaded dendritic cells in Lynch Syndrome subjects who are known to be carrier of a germline MMR-gene mutation without signs of disease.
Phase 1/2 • Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
New DNA test could slash infection failures after broken bone surgery
Disease control Not yet recruitingThe study focuses on the serious problem of infections and wound-healing issues that can happen after high-energy bone fractures. These complications are common and can affect between 10% and 60% of patients, especially those with severe injuries. When a fracture is repaired with…
Phase 3 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Blood test may let some throat cancer patients skip radiation after surgery
Disease control Recruiting nowThis single-arm Phase II trial evaluates whether omission of postoperative radiotherapy is feasible and oncologically safe in select patients with HPV-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC). Eligible patients undergo transoral robotic surgery (TORS) and are …
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New combo aims to shrink tough colon cancers before surgery
Disease control Not yet recruitingIn patients with high-risk stage II and stage III colon cancer, curative surgery followed by adjuvant chemotherapy with FOLFOX or CAPOX regimens has become the standard treatment. However, 20 to 30% of these patients will develop distant metastasis, which ultimately results in de…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control PausedThis clinical trial evaluates the combination of olomorasib and pembrolizumab as a first-line treatment for patients with advanced or metastatic non-small cell lung cancer (NSCLC) that has a Kirsten Rat Sarcoma Virus (KRAS) G12C mutation and a programmed death-ligand (PD-L1) scor…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Double probe heat therapy may slash cervical cancer risk in HIV-positive women
Prevention Not yet recruitingCervical cancer disproportionately affects women in low- and middle-income countries (LMICs), particularly women living with HIV (WLWH) who have a 6-fold increased risk of cervical cancer compared to women in the general population. While thermal ablation (TA) is a WHO- recommend…
Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
New hope for Hard-to-Treat breast cancer: drug combo trial launches
Disease control Not yet recruitingThis study is a prospective, open-label, phase III, randomized controlled clinical trial. It is planned to screen patients with inoperable locally advanced or metastatic triple-negative breast cancer of the BLIS subtype. A total of 140 patients are planned to be enrolled.
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental drug targets rare genitourinary cancers in new trial
Disease control Not yet recruitingRINGQUEST is a Phase 2, open-label, single arm, basket, investigator-initiated clinical trial of sacituzumab tirumotecan in patients with: * Cohort 1: papillary renal carcinoma (pRCC). * Cohort 2: less frequent bladder tumors such as variant histology urothelial carcinoma (VH-UC…
Phase 2 • Sponsor: Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can weekly video coaching help preterm babies find their voice?
Symptom relief Not yet recruitingBabble Boot Camp focuses on early speech and language development, environmental enrichment and supporting parent-infant interaction with the aim of improving communication outcomes and parental well-being in at risk children. The goal of this clinical trial is to learn if this …
Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Six-Gene clue: could a simple test forecast lung spread in breast cancer?
Knowledge-focused Not yet recruitingThe goal of this observational study is to validate the predictive ability of a six-gene risk score model for lung metastasis in patients with early-stage breast cancer. The main questions it aims to answer are: Does the gene risk score accurately identify patients at high risk…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Can a new acid blocker match the standard for stopping GI bleeding?
Disease control Not yet recruitingAcute non-variceal upper gastrointestinal bleeding (ANVUGIB) is a common medical emergency requiring hospitalization. The cornerstone of ANVUGIB management is effective gastric acid suppression. Potassium-competitive acid blockers (P-CABs) represent a novel class of gastric acid …
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a simple drink rebuild strength after a hip fracture?
Symptom relief Not yet recruitingThis study aim to compare the efficacy of oral nutritional supplementation (ONS) in femoral neck fracture patients undergoing hip arthroplasty compared with placebo. The hypothesis is "Oral nutritional supplement with Beta-hydroxy-beta-methylbutyrate (HMB) can improve muscle stre…
Sponsor: Thammasat University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
AI takes on the microscope: a new test for skin cancer diagnosis
Diagnosis Not yet recruitingThe goal of this study is to evaluate the diagnostic performance of an Artificial Intelligence (AI) algorithm in the histopathological diagnosis of bcc compared to certified dermatopathologists
Sponsor: Al-Azhar University • Aim: Diagnosis
Last updated Aug 28, 2026 00:00 UTC
-
Could a health Worker's support break the smoking habit in mental illness?
Disease control Not yet recruitingThe purpose of this study is to learn whether providing additional smoking cessation support through specially trained members of behavioral healthcare team helps people quit smoking and improve their health. Participants ages 18-75 who receive mental health services and smoke ci…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
A gentle current to the brain may curb pain avoidance
Symptom relief Recruiting nowPain avoidance helps with survival. However, chronic pain patients often avoid valued life activities fearing onset or exacerbation of pain. Hence, pain avoidance no longer protects, but reduces quality of life. The goal of this clinical trial is to learn if non-invasive brain st…
Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Smart mask alarms may spot breathing trouble before it turns critical
Disease control Not yet recruitingInvestigators will enroll 493 patients who will undergo non-cardiac surgery, receive supplemental oxygen via face mask or nasal cannula, and will be on continuous pulse oximetry monitor in the Post Anesthesia Care Unit (PACU). Research personnel will screen and select subjects fo…
Sponsor: Linshom Medical, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Mapping the tumor microenvironment to predict prostate cancer therapy outcomes
Knowledge-focused Not yet recruitingThis study plans to enroll patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) and conduct a prospective, single-center, observational study. By performing whole-exome sequencing (WES), Xenium spatial transcriptomics, and PhenoCycler-Fusion spatial …
Phase 2 • Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can listening to music calm anxiety at the end of life?
Symptom relief Not yet recruitingA music therapy intervention can be either receptive or active. In both cases, somatic effects have been observed, with a direct impact on respiratory, cardiac and hemodynamic parameters, as well as psychological effects, creating a relationship of support, accompaniment and list…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can 10 minutes of breathing ease Chemotherapy's toll?
Symptom relief Not yet recruitingThis randomized controlled trial will evaluate the effects of a mobile-delivered remote mindfulness breathing training program on symptom distress, fatigue, anxiety, and depression in adults with cancer who are receiving chemotherapy. A total of 80 participants will be randomly …
Sponsor: Tri-Service General Hospital (TSGH) • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC